FDA approves $2.59 million gene therapy for SMA
The FDA has approved Itvisma (onasemnogene abeparvovec-brve) to treat children two years and older, teens, and adults living with spinal...
Million
Aromatherapy Market Forecast to Hit USD 13,106.40 Million
Aromatherapy MarketThe global aromatherapy market is poised for robust expansion, with its valuation expected to nearly double over the next...
